Dr. Barry Dworkin

Study in Nature outlines how in vitro and in vivo (mouse model), specific white blood cells (B-Cells) can be genetically programmed to produce anti-HIV antibodies thus offer a one-time treatment for the disease. Long way to go but elegant study design.

Medical Mythbusting Commentary for June 15, 2022

Source:
A “One-Time” Treatment for HIV Could Be on the Horizon

Reference:
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

Related posts:

  1. Gene therapy helps retrain immune system to attack HIV
  2. Genes research offers cancer treatment hope
  3. HIV treatment with modified T cells successful in small study
  4. HIV vaccine hopes should not be “dashed” by trial failure. Results contribute to understanding and formulating new approaches. We learn from our mistakes and failures in order to attain our goals.